FIBROUS DYSPLASIA

Clinical trials for FIBROUS DYSPLASIA explained in plain language.

Never miss a new study

Get alerted when new FIBROUS DYSPLASIA trials appear

Sign up with your email to follow new studies for FIBROUS DYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Completed 1

Could a bone drug halt skeletal damage in kids with rare disease?

Disease control Completed

This study tested a drug called denosumab in 15 children aged 4 to 14 with fibrous dysplasia, a rare bone disease that causes weak spots and fractures. The goal was to see if the drug could stop bone lesions from growing during childhood. Participants received injections every 4 …

Matched conditions: FIBROUS DYSPLASIA

Phase: PHASE2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control

Last updated Jun 27, 2026 08:12 UTC

FIBROUS DYSPLASIA

Get alerted when new FIBROUS DYSPLASIA trials appear

Could a bone drug halt skeletal damage in kids with rare disease?